IMUNON, INC. — Income Charts
36 quarters of history · ending 2022-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+0.0% +$0
$125K
R&D↑+0.6% +$17K
$3M
D&A↓-50.6% -$81K
$79K
Operating Income↓-22.0% -$1M
$-6M
EBITDA↓-50.6% -$81K
$79K
Interest Expense↑+57.4% +$55K
$150K
Interest Income
$24K
Net Income↓-13.6% -$738K
$-6M
Operating Margin↓-890.4pts
-4939.7%
Net Margin↓-590.2pts
-4918.6%
Deferred Tax Assets
$184K
ETR (Continuing Operations)↓-2.1pts
4.1%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-0.7pts
7.1%
Operating Lease Cost
$147K
Revenue YoY Variation↑+0.0pts
0.0%
Income YoY Variation↓-0.3pts
-22.0%
Revenue QoQ Variation↑+0.0pts
0.0%
Income QoQ Variation↓-3.5pts
-3.3%